Cita APA (7a ed.)
Mao, X., Ma, K., Wang, Y., Long, C., Tan, X., Chen, X., & Chen, B. (2026). Characterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses. Virchows Archiv: European Journal of Pathology, 489(2), 409-426.
Cita Chicago Style (17a ed.)
Mao, Xueyan, Kang Ma, Yunjie Wang, Cheng Long, Xuejing Tan, Xi Chen, y Bo Chen. "Characterizing Neurofibromin 1-altered Breast Cancer Through Genomic, Functional, and Clinical Analyses." Virchows Archiv: European Journal of Pathology 489, no. 2 (2026): 409-426.
Cita MLA (9a ed.)
Mao, Xueyan, et al. "Characterizing Neurofibromin 1-altered Breast Cancer Through Genomic, Functional, and Clinical Analyses." Virchows Archiv: European Journal of Pathology, vol. 489, no. 2, 2026, pp. 409-426.
Precaución: Estas citas no son 100% exactas.